The FDA’s DDMAC issued a warning letter to AstraZeneca asserting that a company sales rep recommended or suggested to a healthcare professional an off-label use for Seroquel and Seroquel XR. The ...

AstraZeneca today announced it has entered into a settlement agreement in its US SEROQUEL XR® patent infringement litigation against Handa Pharmaceuticals, LLC ("Handa") regarding Handa's proposed ...

AstraZeneca hopes the approval of a once daily version of its blockbuster schizophrenia drug Seroquel can break its streak of bad product news. The FDA is scheduled to make a decision on Seroquel XR ...

Seroquel XR (quetiapine fumarate, from AstraZeneca) extended-release tablets have been launched in two new strengths, 50mg and 150mg. It is indicated for the acute treatment of the depressive episodes ...

The XR in SEROQUEL XR stands for extended release. This means that medication is released around the clock. SEROQUEL XR is taken once daily as prescribed by your health care professional. SEROQUEL XR ...

Sept 29 (Reuters) - AstraZeneca PLC said on Thursday it has reached a settlement with privately held Handa Pharmaceuticals LLC that will keep the company from selling a generic form of its Seroquel XR ...

AstraZeneca's Seroquel XR is one of the key drugs the company banks on.--Courtesy of AstraZeneca AstraZeneca's ($AZN) new CEO Pascal Soriot had to start the year ...

AstraZeneca received good news in the US yesterday when the validity of its patent for Seroquel XR (Quetiapine) was upheld by an appeals court. The verdict by the US Court of Appeals for the Federal ...

Seroquel XR (quetiapine fumarate extended-release tablets, from AstraZeneca) has been approved by the FDA as adjunctive treatment to antidepressants in adults with major depressive disorder (MDD).

SEROQUEL XR is Now Approved to Treat the Depressive, Manic, and Mixed Episodes of Bipolar Disorder WILMINGTON, Del., Feb. 23 /PRNewswire-FirstCall/ -- AstraZeneca ...

LONDON, Oct 21 (Reuters) - AstraZeneca Plc is seeking European approval to sell its drug Seroquel XR as a treatment for anxiety, the Anglo-Swedish group said on Tuesday. If approved, Seroquel XR would ...

Intellipharmaceuticals, which has also challenged the Seroquel XR patent, is not part of that lawsuit. The pill is a longer-acting form of Seroquel, which also treats depression and bipolar disorder.